Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Why CagriSema matters: Designed for adults with overweight or obesity, along with at least one weight-based comorbidity Combines cagrilintide (long-acting amylin analogue) with semaglutide, the GLP-1 behind Ozempic and Wegovy Positioned as the first injectable amylinGLP-1 combination therapy in the sector Clinical edge (REDEFINE 1 Phase 3): 20.4% weight loss at 68 weeks with CagriSema Compared to 14.9% with semaglutide alone, 11.5% with cagrilintide alone, and 3% with placebo Novo Nordisk CEO Maziar Mike Doustdar highlighted the significance, stating that combining semaglutides established profile with a novel mechanism could represent a major step forward in comprehensive obesity treatment
Glutathione is widely recognized for its role in: Supporting antioxidant activity Helping maintain an even-looking skin tone Reducing oxidative stress Promoting overall skin clarity Because it works internally, results are typically gradual and depend on consistent use
Every meal is something you'd actually want to eat
Do not flush used patches in the toilet
US$ 26.22
US$ 26.52
US$ 25.42
US$ 25.24
US$ 20.72
US$ 29.68
US$ 26.57
